Anti-CD3/anti-epidermal growth factor receptor-bispecific antibody retargeting of lymphocytes against human neoplastic keratinocytes in an autologous organotypic culture model
[en] Local cellular immune defects have been described in several tumors including human papillomavirus (HPV)-associated cervical cancer. This observation suggests the potential therapeutic benefit of immune manipulations that restore cellular immunity. Here, we evaluated the ability of bispecific monoclonal antibodies (bimAbs) to redirect T cells against keratinocytes transformed in vitro by HPV in an autologous three-dimensional culture model (organotypic cultures). The epidermal growth factor receptor (EGFR) was chosen as target for an anti-CD3/anti-EGFR bimAb because it is overexpressed in many malignant epithelial lesions and only weakly expressed in the basal layers of normal squamous epithelium. Interestingly, in organotypic cultures, the pattern of expression of EGFR was similar to that observed in vivo. The ability of T cells retargeted by CD3/EGFR bimAb to lyse HPV-transformed cell lines was confirmed in monolayer cultures. In autologous organotypic cultures, an increase in apoptotic HPV(+) keratinocytes and a significant decrease in the thickness of HPV(+) organotypic cultures were observed when activated lymphocytes and bimAbs were added to the cultures, whereas organotypic cultures of normal keratinocytes were not significantly affected. These data were similar to those obtained in the allogeneic model. These results suggest the potential usefulness of CD3-EGFR bimAb-retargeted lymphocytes in immunotherapeutic protocols for malignant epithelial lesions.
Disciplines :
Biotechnology Immunology & infectious disease
Author, co-author :
Renard, I.
Mezzanzanica, Delia
Canevari, Silvana
Ferrini, Silvano
Boniver, Jacques ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques
Delvenne, Philippe ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques
Jacobs, Nathalie ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques
Language :
English
Title :
Anti-CD3/anti-epidermal growth factor receptor-bispecific antibody retargeting of lymphocytes against human neoplastic keratinocytes in an autologous organotypic culture model
Publication date :
January 2002
Journal title :
American Journal of Pathology
ISSN :
0002-9440
eISSN :
1525-2191
Publisher :
Amer Soc Investigative Pathology, Inc, Bethesda, United States - Maryland
Volume :
160
Issue :
1
Pages :
113-122
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
F.R.S.-FNRS - Fonds de la Recherche Scientifique FRIA - Fonds pour la Formation à la Recherche dans l'Industrie et dans l'Agriculture Région wallonne Fonds Léon Fredericq EU contract BIO4-CT98-0097 Consiglio Nazionale delle Ricerche Target Project on Biotechnology GSK - GlaxoSmithKline
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Faure F., Even J., Kourilsky P. (1998) Tumor-specific immune response: Current in vitro analyses may not reflect the in vivo immune status. Crit Rev Immunol 18:77-86.
Segal D.M., Weiner G.J., Weiner L.M. (1999) Bispecific antibodies in cancer therapy. Curr Opin Immunol 11:558-562.
Chapman W.B., Lorincz A.T., Willett G.D., Wright V.C., Kurman R.J. (1992) Epidermal growth factor receptor expression and the presence of human papillomavirus in cervical squamous intraepithelial lesions. Int J Gynecol Pathol 11:221-226.
Gullick W.J., Marsden J.J., Whittle N., Ward B., Bobrow L., Waterfield M.D. (1986) Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas. Cancer Res 46:285-292.
Hansen L.A., Woodson II R.L., Holbus S., Strain K., Lo Y.C., Yuspa S.H. (2000) The epidermal growth factor receptor is required to maintain the proliferative population in the basal compartment of epidermal tumors. Cancer Res 60:3328-3332.
Tosi E., Valota O., Negri D.R., Adobati E., Mazzoni A., Meazza R., Ferrini S., Colnaghi M.I., Canevari S. (1995) Anti-tumor efficacy of an anti-epidermalgrowth-factor-receptor monoclonal antibody and its F(ab′)2 fragment against high- and low-EGFR-expressing carcinomas in nude mice. Int J Cancer 62:643-650.
Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., Munoz N. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
Zur Hausen H. (2000) Papillomaviruses causing cancer: Evasion from hostcell control in early events in carcinogenesis. J Natl Cancer Inst 92:690-698.
Hu G., Liu W., Mendelsohn J., Ellis L.M., Radinsky R., Andreeff M., Deisseroth A.B. (1997) Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells. J Natl Cancer Inst 89:1271-1276.
Straight S.W., Hinkle P.M., Jewers R.J., McCance D.J. (1993) The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J Virol 67:4521-4532.
Kersemaekers A.M., Fleuren G.J., Kenter G.G., Van den Broek L.J., Uljee S.M., Hermans J., Van de Vijver M.J. (1999) Oncogene alterations in carcinomas of the uterine cervix: Overexpression of the epidermal growth factor receptor is associated with poor prognosis. Clin Cancer Res 5:577-586.
Aebischer F., McDougall J.K. (1997) Organotypic raft cultures for the in vitro evaluation of vaginal microbicidal agents. Microbicides have epithelium-specific effects when repeatedly added onto organotypic human keratinocyte cultures. Sex Transm Dis 24:69-76.
Delvenne P., Al-Saleh W., Gilles C., Thiry A., Boniver J. (1995) Inhibition of growth of normal and human papillomavirus-transformed keratinocytes in monolayer and organotypic cultures by interferon γ and tumor necrosis factor α. Am J Pathol 146:589-598.
Eicher S.A., Clayman G.L., Liu T.J., Shillitoe E.J., Storthz K.A., Roth J.A., Lotan R. (1996) Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model. Clin Cancer Res 2:1659-1664.
Jacobs N., Moutschen M.P., Franzen-Detrooz E., Boniver V., Boniver J., Delvenne P. (1998) Organotypic culture of HPV-transformed keratinocytes: A model for testing lymphocyte infiltration of (pre)neoplastic lesions of the uterine cervix. Virchows Arch 432:323-330.
Blanton R.A., Perez-Reyes N., Merrick D.T., McDougall J.K. (1991) Epithelial cells immortalized by human papillomaviruses have premalignant characteristics in organotypic culture. Am J Pathol 138:673-685.
McCance D.J., Kopan R., Fuchs E., Laimins L. (1988) Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc Natl Acad Sci USA 85:7169-7173.
Merrick D.T., Blanton R.A., Gown A.M., McDougall J.K. (1992) Altered expression of proliferation and differentiation markers in human papillomavirus 16 and 18 immortalized epithelial cells grown in organotypic culture. Am J Pathol 140:167-177.
Ferrini S., Cambiaggi A., Sforzini S., Marciano S., Canevari S., Mezzanzanica D., Colnaghi M.I., Grossi C.E., Moretta L. (1993) Targeting of T lymphocytes against EGF-receptor+ tumor cells by bispecific monoclonal antibodies: Requirement of CD3 molecule cross-linking for T-cell activation. Int J Cancer 55:931-937.
Gilles C., Piette J., Rombouts S., Laurent C., Foidart J.M. (1993) Immortalization of human cervical keratinocytes by human papillamavirus type 33. Int J Cancer 53:872-879.
Friedl F., Kimura I., Osato T., Ito Y. (1970) Studies on a new human cell line (SiHa) derived from carcinoma of uterus. I. Its establishment and morphology. Proc Soc Exp Biol Med 135:543-545.
Pater M., Pater A. (1985) Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology 145:313-318.
Auersperg N., Hawryluk A.F. (1962) Chromosome observations on three epithelial cell cultures derived from carcinomas of the uterine cervix. J Natl Cancer Inst 28:605-627.
Andrade W.N., Johnston M.G., Hay J.B. (1996) A method for tracking the migration of blood lymphocytes. Immunol Invest 25:455-467.
Ferini S., Biassoni R., Moretta A., Bruzzone M., Nicolin A., Moretta L. (1985) Clonal analysis of T lymphocytes isolated from ovarian carcinoma ascitic fluid. Phenotypic and functional characterization of T-cell clones capable of lysing autologous carcinoma cells. Int J Cancer 36:337-343.
Mazzoni A., Mezzanzanica D., Jung G., Wolf H., Colnaghi M.I., Canevari S. (1996) CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma. Cancer Res 56:5443-5449.
Qian J.H., Titus J.A., Andrew S.M., Mezzanzanica D., Garrido M.A., Wunderlich J.R., Segal D.M. (1991) Human peripheral blood lymphocytes targeted with bispecific antibodies release cytokines that are essential for inhibiting tumor growth. J Immunol 146:3250-3256.
Negri D.R., Tosi E., Valota O., Ferrini S., Cambiaggi A., Sforzini S., Silvani A., Ruffini P.A., Colnaghi M.I., Canevari S., Knuth A., Bernhard H., Jager E., Woltel T., Karbach J., Jaggle C., Strittmatter W., Meyer zum Buschenfelde K.H. (1995) In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/ anti-CD3 F(ab′)2 bispecific monoclonal antibody: Induction of tumour cell lysis by a bispecific antibody recognising epidermal growth factor receptor (EGFR) and CD3. Br J Cancer 72:928-933.
Zeidler R., Reisbach G., Wollenberg B., Lang S., Chaubal S., Schmitt B., Lindhofer H. (1999) Simultaneous activation of T cells and accessory cells by a new class of intact bispecific antibody results in efficient tumor cell killing. J Immunol 163:1246-1252.
Hahn C.S., French O.G., Foley P., Martin E.N., Taylor R.P. (2001) Bispecific monoclonal antibodies mediate binding of dengue virus to erythrocytes in a monkey model of passive viremia. J Immunol 166:1057-1065.
Sundarapandiyan K., Keler T., Behnke D., Engert A., Barth S., Matthey B., Dec Y.M., Graziano R.F. (2001) Bispecific antibody-mediated destruction of Hodgkin's lymphoma cells. J Immunol Methods 248:113-123.
Sauter G., Maeda T., Waldman F.M., Davis R.L., Feuerstein B.G. (1996) Patterns of epidermal growth factor receptor amplification in malignant gliomas. Am J Pathol 148:1047-1053.
Pfeiffer D., Kimmig R., Herrmann J., Ruge M., Fisseler-Eckhoff A., Scheidel P., Jensen A., Schatz H., Pfeiffer A. (1998) Epidermal-growth-factor receptor correlates negatively with cell density in cervical squamous epithelium and is down-regulated in cancers of the human uterus. Int J Cancer 79:49-55.
Kimmig R., Pfeiffer D., Landsmann H., Hepp H. (1997) Quantitative determination of the epidermal growth factor receptor in cervical cancer and normal cervical epithelium by 2-color flow cytometry: Evidence for down-regulation in cervical cancer. Int J Cancer 74:365-373.
Yang X.D., Jia X.C., Corvalan J.R., Wang P., Davis C.G., Jakobovits A. (1999) Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy. Cancer Res 59:1236-1243.
Hoffmann T.K., Meidenbauer N., Dworacki G., Kanaya H., Whiteside T.L. (2000) Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells. Cancer Res 60:3542-3549.
Russo V., Tanzarella S., Dalerba P., Rigatti D., Rovere P., Villa A., Bordignon C., Traversari C. (2000) Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response. Proc Natl Acad Sci USA 97:2185-2190.
Talmadge J.E., Tribble H.R., Pennington R.W., Phillips H., Wiltrout R.H. (1987) Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice. Cancer Res 47:2563-2570.
Tannenbaum C.S., Hamilton T.A. (2000) Immune-inflammatory mechanisms in IFNgamma-mediated anti-tumor activity. Semin Cancer Biol 10:113-123.
Schiller J.H., Bittner G., Storer B., Willson J.K. (1987) Synergistic antitumor effects of tumor necrosis factor and gamma-interferon on human colon carcinoma cell lines. Cancer Res 47:2809-2813.
Nanus D.M., Geng Y., Shen R., Lai H.K., Pfeffer S.R., Pfeffer L.M. (2000) Interaction of retinoic acid and interferon in renal cancer cell lines. J Interferon Cytokine Res 20:787-794.
Yano T., Sugio K., Yamazaki K., Kase S., Yamaguchi M., Ondo K., Sugimachi K. (2000) Direct influence of interferon-gamma on proliferation and cell-surface antigen expression of non-small cell lung cancer cells. Lung Cancer 30:169-174.
Al-Saleh W., Delvenne P., Arrese Estrada J.E., Nikkels A.F., Pierard G.E., Boniver J. (1995) Inverse modulation of intraepithelial Langerhans cells and stromal macrophage populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix. Virchows Arch 427:41-48.
Biron C.A. (1997) Activation and function of natural killer cell responses during viral infections. Curr Opin Immunol 9:24-34.
Connor M.E., Stern P.L. (1990) Loss of MHC class-I expression in cervical carcinomas. Int J Cancer 46:1029-1034.
Gilboa E. (1999) How tumors escape immune destruction and what we can do about it. Cancer Immunol Immunother 48:382-385.
Coleman N., Greenfield I.M., Hare J., Kruger-Gray H., Chain B.M., Stanley M.A. (1993) Characterization and functional analysis of the expression of intercellular adhesion molecule-1 in human papillomavirus-related disease of cervical keratinocytes. Am J Pathol 143:355-367.
Jacobs N., Greimers R., Mazzoni A., Trebak M., Schaaf-Lafontaine N., Boniver J., Moutschen M.P. (1996) Further characterization of cytotoxic T cells generated by short-term culture of human peripheral blood lymphocytes with interleukin-2 and anti-CD3 mAb. Cancer Immunol Immunother 42:369-375.
Ferrini S., Sforzini S., Cambiaggi A., Poggi A., Meazza R., Canevari S., Colnaghi M.I., Moretta L. (1994) The LFA-1/ICAM cell adhesion pathway is involved in tumor-cell lysis mediated by bispecific monoclonal-antibody-targeted T lymphocytes. Int J Cancer 56:846-852.
Van Spriel A.B., Van Ojik H.H., Van De Winkel J.G. (2000) Immunotherapeutic perspective for bispecific antibodies. Immunol Today 21:391-397.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
